219 related articles for article (PubMed ID: 32555504)
1. CRISPR/Cas9 knockout of human arylamine N-acetyltransferase 1 in MDA-MB-231 breast cancer cells suggests a role in cellular metabolism.
Carlisle SM; Trainor PJ; Hong KU; Doll MA; Hein DW
Sci Rep; 2020 Jun; 10(1):9804. PubMed ID: 32555504
[TBL] [Abstract][Full Text] [Related]
2. Knockout of human arylamine N-acetyltransferase 1 (NAT1) in MDA-MB-231 breast cancer cells leads to increased reserve capacity, maximum mitochondrial capacity, and glycolytic reserve capacity.
Carlisle SM; Trainor PJ; Doll MA; Stepp MW; Klinge CM; Hein DW
Mol Carcinog; 2018 Nov; 57(11):1458-1466. PubMed ID: 29964355
[TBL] [Abstract][Full Text] [Related]
3. Genetic and small molecule inhibition of arylamine N-acetyltransferase 1 reduces anchorage-independent growth in human breast cancer cell line MDA-MB-231.
Stepp MW; Doll MA; Carlisle SM; States JC; Hein DW
Mol Carcinog; 2018 Apr; 57(4):549-558. PubMed ID: 29315819
[TBL] [Abstract][Full Text] [Related]
4. Human Arylamine
Carlisle SM; Trainor PJ; Doll MA; Hein DW
Front Pharmacol; 2021; 12():803254. PubMed ID: 35046826
[TBL] [Abstract][Full Text] [Related]
5. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.
Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM
Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847
[TBL] [Abstract][Full Text] [Related]
6. Untargeted polar metabolomics of transformed MDA-MB-231 breast cancer cells expressing varying levels of human arylamine
Carlisle SM; Trainor PJ; Yin X; Doll MA; Stepp MW; States JC; Zhang X; Hein DW
Metabolomics; 2016 Jul; 12(7):. PubMed ID: 27872580
[TBL] [Abstract][Full Text] [Related]
7. From arylamine N-acetyltransferase to folate-dependent acetyl CoA hydrolase: impact of folic acid on the activity of (HUMAN)NAT1 and its homologue (MOUSE)NAT2.
Laurieri N; Dairou J; Egleton JE; Stanley LA; Russell AJ; Dupret JM; Sim E; Rodrigues-Lima F
PLoS One; 2014; 9(5):e96370. PubMed ID: 24823794
[TBL] [Abstract][Full Text] [Related]
8. Modulation of Human Arylamine
Butcher NJ; Burow R; Minchin RF
Mol Pharmacol; 2020 Aug; 98(2):88-95. PubMed ID: 32487734
[TBL] [Abstract][Full Text] [Related]
9. Role for human arylamine N-acetyltransferase 1 in the methionine salvage pathway.
Witham KL; Minchin RF; Butcher NJ
Biochem Pharmacol; 2017 Feb; 125():93-100. PubMed ID: 27865712
[TBL] [Abstract][Full Text] [Related]
10. Deletion of arylamine N-acetyltransferase 1 in MDA-MB-231 human breast cancer cells reduces primary and secondary tumor growth in vivo with no significant effects on metastasis.
Doll MA; Ray AR; Salazar-González RA; Shah PP; Vega AA; Sears SM; Krueger AM; Hong KU; Beverly LJ; Hein DW
Mol Carcinog; 2022 May; 61(5):481-493. PubMed ID: 35133049
[TBL] [Abstract][Full Text] [Related]
11. Arylamine N-acetyltransferase 1 expression in breast cancer cell lines: a potential marker in estrogen receptor-positive tumors.
Wakefield L; Robinson J; Long H; Ibbitt JC; Cooke S; Hurst HC; Sim E
Genes Chromosomes Cancer; 2008 Feb; 47(2):118-26. PubMed ID: 17973251
[TBL] [Abstract][Full Text] [Related]
12. Arylamine N-acetyltransferase 1 protects against reactive oxygen species during glucose starvation: Role in the regulation of p53 stability.
Wang L; Minchin RF; Butcher NJ
PLoS One; 2018; 13(3):e0193560. PubMed ID: 29518119
[TBL] [Abstract][Full Text] [Related]
13. Identification of the xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 as a new target of cisplatin in breast cancer cells: molecular and cellular mechanisms of inhibition.
Ragunathan N; Dairou J; Pluvinage B; Martins M; Petit E; Janel N; Dupret JM; Rodrigues-Lima F
Mol Pharmacol; 2008 Jun; 73(6):1761-8. PubMed ID: 18310302
[TBL] [Abstract][Full Text] [Related]
14. Human arylamine N-acetyltransferase 1: a drug-metabolizing enzyme and a drug target?
Rodrigues-Lima F; Dairou J; Busi F; Dupret JM
Curr Drug Targets; 2010 Jun; 11(6):759-66. PubMed ID: 20041842
[TBL] [Abstract][Full Text] [Related]
15. Effect arylamine N-acetyltransferase 1 on morphology, adhesion, migration, and invasion of MDA-MB-231 cells: role of matrix metalloproteinases and integrin αV.
Li P; Butcher NJ; Minchin RF
Cell Adh Migr; 2020 Dec; 14(1):1-11. PubMed ID: 31910058
[TBL] [Abstract][Full Text] [Related]
16. Effect of arylamine acetyltransferase Nat3 gene knockout on N-acetylation in the mouse.
Sugamori KS; Brenneman D; Wong S; Gaedigk A; Yu V; Abramovici H; Rozmahel R; Grant DM
Drug Metab Dispos; 2007 Jul; 35(7):1064-70. PubMed ID: 17403913
[TBL] [Abstract][Full Text] [Related]
17. Phenotype of the most common "slow acetylator" arylamine N-acetyltransferase 1 genetic variant (NAT1*14B) is substrate-dependent.
Millner LM; Doll MA; Cai J; States JC; Hein DW
Drug Metab Dispos; 2012 Jan; 40(1):198-204. PubMed ID: 22010219
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of cytidine deaminase in NAT1 knockout breast cancer cells.
Hong KU; Tagnedji AH; Doll MA; Walls KM; Hein DW
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5047-5060. PubMed ID: 36329350
[TBL] [Abstract][Full Text] [Related]
19. Arylamine N-acetyltransferase 1 in situ N-acetylation on CD3+ peripheral blood mononuclear cells correlate with NATb mRNA and NAT1 haplotype.
Salazar-González RA; Turiján-Espinoza E; Hein DW; Niño-Moreno PC; Romano-Moreno S; Milán-Segovia RC; Portales-Pérez DP
Arch Toxicol; 2018 Feb; 92(2):661-668. PubMed ID: 29043425
[TBL] [Abstract][Full Text] [Related]
20. Deletion of a xenobiotic metabolizing gene in mice affects folate metabolism.
Wakefield L; Cornish V; Long H; Griffiths WJ; Sim E
Biochem Biophys Res Commun; 2007 Dec; 364(3):556-60. PubMed ID: 17961509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
